Search for: "GlaxoSmithKline LLC"
Results 41 - 60
of 181
Sort by Relevance
|
Sort by Date
15 Dec 2020, 12:21 pm
Certified Aviation Services, LLC (automation & eligibility) [EcoWashingMachine][CAFC Decision] GlaxoSmithKline LLC v. [read post]
6 Dec 2020, 9:59 pm
GlaxoSmithKline LLC. [read post]
25 Nov 2020, 9:45 am
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
25 Nov 2020, 9:45 am
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
19 Nov 2020, 3:18 pm
GSK lost its appeal at the CAFC: Following trial, a jury in the United States District Court for the District of Delaware found that defendants GlaxoSmithKline LLC and Glaxo Group Limited (collectively, “GSK”) infringed U.S. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
9 Nov 2020, 3:00 am
GlaxoSmithKline LLC; Pfizer Inc. [read post]
2 Nov 2020, 1:41 pm
The Federal Circuit decision in GlaxoSmithKline LLC v. [read post]
8 Oct 2020, 9:59 pm
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
6 Oct 2020, 8:19 am
GlaxoSmithKline LLC v. [read post]
5 Oct 2020, 1:15 pm
In GlaxoSmithKline LLC v. [read post]
5 Oct 2020, 1:15 pm
In GlaxoSmithKline LLC v. [read post]
8 Sep 2020, 6:56 am
GlaxoSmithKline LLC v. [read post]
18 May 2020, 8:38 am
GlaxoSmithKline LLC, 713 F.3d 1090, 1096 (Fed.Cir. 2013) (“If an applicant chooses, she can challenge an examiner’s characterization in order to avoid any chancefor disclaimer, but the applicants in this case did not directly challenge the examiner’s characterization. [read post]
24 Dec 2019, 8:06 am
Others are large incumbent companies with massive patent portfolios, like GlaxoSmithKline, Qualcomm, and IBM. [read post]
1 Oct 2019, 7:00 am
GlaxoSmithKline, LLC. [read post]
11 Jun 2019, 5:12 am
GlaxoSmithKline recently announced a $300 million deal with 23 and Me to further commercialize the latter’s genetic data to identify patients with certain rare disorders for drug development and clinical trial design. [read post]
30 May 2019, 6:02 am
GlaxoSmith Kline LLC that federal law prevented GlaxoSmithKline from adding a suicide warning label to the drug. [read post]
20 Feb 2019, 8:43 pm
Noonan -- Sherry Knowles, former chief patent counsel of GlaxoSmithKline, and Dr. [read post]
